American Oncology Network, Inc.
AONC
$4.80
$0.000.00%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 7.81% | 19.43% | |||
| Total Other Revenue | 115.28% | -21.16% | |||
| Total Revenue | 8.36% | 19.11% | |||
| Cost of Revenue | 7.21% | 13.99% | |||
| Gross Profit | 24.29% | 212.99% | |||
| SG&A Expenses | -5.44% | 29.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.15% | 15.16% | |||
| Operating Income | 124.44% | 61.11% | |||
| Income Before Tax | 62.97% | 84.37% | |||
| Income Tax Expenses | -- | -111.20% | |||
| Earnings from Continuing Operations | 59.14% | 87.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -96.92% | -60.60% | |||
| Net Income | -129.52% | 146.18% | |||
| EBIT | 124.44% | 61.11% | |||
| EBITDA | 187.97% | 69.71% | |||
| EPS Basic | -254.26% | 110.00% | |||
| Normalized Basic EPS | -109.22% | -18.78% | |||
| EPS Diluted | -69.19% | 90.81% | |||
| Normalized Diluted EPS | -130.07% | -75.09% | |||
| Average Basic Shares Outstanding | 16.59% | 51.14% | |||
| Average Diluted Shares Outstanding | -64.24% | 392.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
